本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2020/7/171 分钟阅读
Eli Lilly and Co.; Announcement of the Revocation of the Biologics License for LARTRUVO
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA or Agency) is announcing the revocation of the biologics license application (BLA) for LARTRUVO (olaratumab) injection. Eli Lilly and Co. requested withdrawal (revocation) of the biologics license application and has waived its opportunity for a hearing.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →